Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.306, 2001-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
COX-2s confer QOL benefit in clinical practice in Latin America
Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. :
Access to resources
Recommend
COX-2s confer QOL benefit in clinical practice in Latin America
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 458, 2004-01 ,pp. :
Torasemide for HF improves clinical outcomes and QOL
Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. :
Exemestane: clinical benefits without QOL compromise
Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. :
Exemestane: clinical benefits without QOL compromise
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 499, 2006-01 ,pp. :